Accrued other expenses consisted of the following amounts (in thousands):
As of June 30,
As of December 31,
2026
2025
Accrued research and development costs
$
4,228
7,161
Accrued other
961
759
Total accrued other expenses
5,189
7,920
No definition available.
Tabular disclosure of the components of accrued liabilities.